Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service, Trade Show

Elliptic Labs Signs New Expansion License Contract with Global Top-5 Smartphone Customer Transsion


Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in over 500 million devices, is announcing a new license contract with existing global top-5 smartphone customer Transsion. This contract encompasses the usage of Elliptic Labs' AI Virtual Proximity Sensortm INNER BEAUTY® for several future smartphone deployments.

"It was exciting to meet with our customer Transsion at MWC in Barcelona, where we've just signed an expansion contract for more smartphones," said Laila Danielsen, CEO of Elliptic Labs. "Transsion, ranked as the fifth-largest smartphone OEM in the world, has chosen Elliptic Labs' AI Virtual Smart Sensor Platformtm to make more of their smartphones greener, smarter, and more human-friendly. We are delighted with their choice."

INNER BEAUTY is a registered trademark of Elliptic Labs.

AI Virtual Smart Sensor, AI Virtual Proximity Sensor, and AI Virtual Smart Sensor Platform are trademarks of Elliptic Labs.

All other trademarks or service marks are the responsibility of their respective organizations.

AI Virtual Proximity Sensor INNER BEAUTY

Elliptic Labs' AI Virtual Proximity Sensor detects when a user holds their phone up to their ear during a call, allowing the smartphone to turn off its display and disable its screen's touch functionality. This keeps the user's ear or cheek from triggering unwanted actions during the call, such as hanging up or dialing numbers. Turning off the screen also helps conserve battery life.

Proximity detection is a core capability that is used in all smartphones, but Elliptic Labs' AI Virtual Proximity Sensor is a unique, software-only solution that delivers robust proximity detection without the need for a dedicated hardware sensor. By replacing hardware sensors with software sensors, the AI Virtual Proximity Sensor reduces device cost and eliminates sourcing risk.

About Elliptic Labs

Elliptic Labs is a global enterprise targeting the smartphone, laptop, IoT, and automotive markets. Founded in 2006 as a research spin-off from Norway's Oslo University, the company's patented software uses AI, ultrasound and sensor fusion to deliver intuitive 3D gesture, proximity-, presence-, breathing- and heartbeat-detection experiences. Its scalable AI Virtual Smart Sensor Platform creates software-only sensors that are sustainable, human-friendly and already deployed in hundreds of millions of devices around the world. Elliptic Labs is the only software company that has delivered detection capabilities using AI software, ultrasound, and sensor fusion deployed at scale. The company joined the Oslo Børs main listing in March 2022.

Elliptic Labs is headquartered in Norway with presence in the USA, China, South Korea, Taiwan, and Japan. Its technology and IP are developed in Norway and are solely owned by the company.


These press releases may also interest you

at 03:29
Ericsson's annual general meeting on April 3, 2024 authorized the company to, in conjunction with the delivery of vested shares under the long-term variable compensation program 2021 ("LTV 2021"), prior to the annual general meeting in 2025, retain...

at 03:21
W3 Energy and Schierloh Engineering Group are pleased to announce a collaborative partnership to enhance the technical operation of wind farms across Germany. This strategic alliance will enable Schierloh Engineering GmbH to ensure uninterrupted...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:38
Sivers Semiconductors AB (STO: SIVE), a leading supplier of integrated chips and modules for advanced communications and sensor solutions for AI Photonics, SATCOM and 5G/6G today reported its first-quarter results for the fiscal year 2024. The...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...



News published on and distributed by: